Gilead Sciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2007 | — | — | $968.1M |
| FY2008 | $2.66B | $6.94B | $1.46B |
| FY2009 | $3.33B | $9.70B | $1.27B |
| FY2010 | $5.73B | $11.59B | $907.9M |
| FY2011 | $10.56B | $17.30B | $9.88B |
| FY2012 | $11.94B | $21.24B | $1.80B |
| FY2013 | $11.21B | $22.58B | $2.11B |
| FY2014 | $19.24B | $34.66B | $10.03B |
| FY2015 | $33.18B | $51.72B | $12.85B |
| FY2016 | $38.09B | $56.98B | $8.23B |
| FY2017 | $49.84B | $70.28B | $7.59B |
| FY2018 | $42.29B | $63.68B | $17.94B |
| FY2019 | $39.10B | $61.63B | $11.63B |
| FY2020 | $50.21B | $68.41B | $6.00B |
| FY2021 | $46.88B | $67.95B | $5.34B |
| FY2022 | $41.93B | $63.17B | $5.41B |
| FY2023 | $39.29B | $62.13B | $6.09B |
| FY2024 | $39.67B | $59.00B | $9.99B |
| FY2025 | $36.32B | $59.02B | $7.56B |